INSERM U, Cancer Research Center of Toulouse, CHU Rangueil, France.
Anticancer Agents Med Chem. 2011 Nov;11(9):844-53. doi: 10.2174/187152011797655131.
Autophagy is an evolutionary conserved process by which cells recycle intracellular materials to maintain homeostasis in different cellular contexts. Under basal conditions it prevents accumulation of damaged proteins and organelles; during starvation, autophagy provides cells with sufficient nutrients to survive. Sphingolipids are a family of bioactive molecules modulating vital cellular functions such as apoptosis, cell cycle arrest or proliferation. Besides these functions, some sphingolipids like ceramide, sphingosine- 1-phosphate or gangliosides have been described to promote autophagy in several cancer cell lines. Current evidence supports the notion that induction of autophagic cell death can halt tumorigenesis. Of interest, some chemotherapeutic agents used for the treatment of hematological malignancies trigger the production of endogenous sphingolipids with pro-autophagic effects. In this review we describe the regulation and functions of the sphingolipid-induced autophagy and the tight relationship with the cancer cell response to current chemotherapeutic regimens.
自噬是一种进化上保守的过程,通过该过程细胞可以回收细胞内的物质,以在不同的细胞环境中维持体内平衡。在基础条件下,它可以防止受损蛋白质和细胞器的积累;在饥饿时,自噬为细胞提供足够的营养物质以维持生存。鞘脂类是一类生物活性分子,可以调节细胞凋亡、细胞周期停滞或增殖等重要的细胞功能。除了这些功能外,一些鞘脂类物质,如神经酰胺、鞘氨醇 1-磷酸或神经节苷脂,已被描述在几种癌细胞系中促进自噬。目前的证据支持这样一种观点,即诱导自噬性细胞死亡可以阻止肿瘤发生。值得注意的是,一些用于治疗血液系统恶性肿瘤的化疗药物会触发具有促进自噬作用的内源性鞘脂类物质的产生。在这篇综述中,我们描述了鞘脂类诱导的自噬的调控和功能,以及其与癌细胞对当前化疗方案的反应之间的紧密关系。